VeriMomHamilelikte hexyl salicylate kullanmaktan kaçınmalı mıyım? | VeriMom
Hexyl salicylate has been assessed by ECHA/RAC and recommended for harmonised classification as Repr.2 (H361d, 'suspected of damaging the unborn child'), which supports a 'suspected' reproductive hazard. The mechanistic evidence for reproductive toxicity is limited (SCCS and RAC noted concerns including potential endocrine-related effects but did not identify a well-characterised molecular mechanism), so mechanism is scored as theoretical. Topical cosmetic use gives measurable systemic exposure for a lipophilic ester (log Kow ~5) and the SCCS performed exposure-driven assessments and set use/concentration limits, consistent with a moderate exposure score.
ECHA regulatory hazard statements
- •H361D
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- hexyl salicylate hamilelikte güvenli mi?
- Hexyl salicylate has been assessed by ECHA/RAC and recommended for harmonised classification as Repr.2 (H361d, 'suspected of damaging the unborn child'), which supports a 'suspected' reproductive hazard. The mechanistic evidence for reproductive toxicity is limited (SCCS and RAC noted concerns including potential endocrine-related effects but did not identify a well-characterised molecular mechanism), so mechanism is scored as theoretical. Topical cosmetic use gives measurable systemic exposure for a lipophilic ester (log Kow ~5) and the SCCS performed exposure-driven assessments and set use/concentration limits, consistent with a moderate exposure score.
- hexyl salicylate emzirirken güvenli mi?
- Because hexyl salicylate is classified Repr.2 (H361d) and is lipophilic with potential for systemic absorption after topical use, a similar 'suspected' hazard rating is applied for breastfeeding. There is no high-quality human milk transfer data or demonstrated mechanism linked specifically to lactational transfer, so mechanism is theoretical, and exposure from topical use is rated moderate (SCCS evaluated consumer exposures).
- hexyl salicylate bebek cildi için güvenli mi?
- SCCS assessed hexyl salicylate for children 0–3 years and provided guidance/limits; combined with the harmonised Repr.2 classification the hazard remains 'suspected' for infant exposure. Mechanistic data specific to infants is lacking. Because infant skin has higher surface-area-to-weight and immature barrier function, exposure is increased by +1 (moderate→high) relative to adults for topical use — SCCS specifically considered young children in its addendum.
- VeriMom hexyl salicylate nasıl puanlıyor?
- VeriMom hexyl salicylate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 20/100 (yüksek risk) olarak puanlar.
- Hamilelikte hexyl salicylate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.